Advanced Tactile Imaging, Inc

Ricovr Healthcare Inc is a Princeton-based company that specializes in breakthrough technology for rapid-results testing. Their flagship product, XALIVA, is a portable saliva-based testing device that provides accurate results within just 5 minutes. With its intuitive workflow and cost-effective solution, XALIVA is set to revolutionize testing in various industries, including healthcare, law enforcement, and employment. By harnessing the power of nanoparticles, Ricovr Healthcare has developed a testing platform that offers true portability and ultra-sensitivity to the nanogram level. Saliva, which is widely accepted and used for diagnostic medical tests, is the preferred method of detection due to its speed, accuracy, and ease of testing. With XALIVA, employers, healthcare systems, and law enforcement agencies can now obtain actionable data quickly and non-invasively, making it the go-to analytics tool for rapid-results testing.Generated from the website

Rex Medical specializes in the development, manufacturing and marketing of medical devices for cardiology, endosurgery and oncology. The company has received an ISO 9001 certification from the International Organization for Standardization. It offers apparatus, urinary catheters, umbilical cord clips and applicators, surgical retractors, coil fasteners appliers, dialysis needles and atherectomy devices. Rex Medical additionally provides online information about several medical trade shows, meetings and seminars.

NeuroDx Development, located in Morrisville, PA, specializes in innovative solutions for monitoring cerebrospinal fluid (CSF) flow through its ShuntCheck technology. This non-invasive thermal dilution method is designed to detect fluid flow in CSF shunts, helping clinicians address potential obstructions and clarify diagnostic uncertainties. The company is actively involved in advancing pediatric neurological care, as evidenced by its ShuntCheck Prospective Multi-Center Pediatric Outcomes Study published in the journal Neurosurgery. By providing critical insights into CSF flow, NeuroDx Development aims to enhance patient outcomes and streamline clinical decision-making processes in managing shunt-related issues. Generated from the website